Mimosa Therapeutics, A Public Benefit Corp — Form D
Mimosa Therapeutics, A Public Benefit Corp of ALAMEDA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-10. The offering totals $1.7M, of which $865K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-02-10
- Form: D
- Accession: 0001844977-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $865K
- Remaining: $811K
- Investors: 4
- Date of first sale: 2021-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389071
Issuer
- Name: Mimosa Therapeutics, A Public Benefit Corp
- CIK: 0001844977
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 780 TAYLOR AVENUE, APT. A, ALAMEDA, CA, 94501
- Phone: 5106933914
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robert Stanley | Director | Chapel Hill, NC |
| Stephen Apkon | Director | Ashville, NC |
| James Keim | Director | Alameda, CA |
| James Keim | Executive Officer | Alameda, CA |
| James Keim | Promoter | Alameda, CA |
| Amanda Feilding | Director | Alameda, CA |
Other filings by this issuer (1)
More